Merck Slips 2.66% as Major Indexes Post Mixed Results
The decline outpaced the S&P 500 as Merck’s October earnings report approaches, with consensus forecasts pointing to lower quarterly earnings.
Merck shares fell 2.66% to $145.31 in the latest session, underperforming the S&P 500, which lost 0.25%. The Dow fell 0.86%, while the Nasdaq rose 0.24%.
The decline came after Merck shares lost 0.39% over the prior month. The Medical sector fell 1.01% over that period, while the S&P 500 was down 0.42%. The report did not identify a company-specific catalyst for the latest drop.
Merck is scheduled to report earnings on October 29, 2026. Zacks consensus estimates project quarterly earnings of $2.25 per share, down 12.79% from the year-earlier quarter, and revenue of $17.52 billion, up 1.39%.
For the year, Zacks consensus estimates put earnings at $2.77 per share and revenue at $67.25 billion. Those figures represent a 69.15% decline in earnings and a 3.44% increase in revenue from the prior year. The consensus quarterly EPS estimate was revised 0.07% lower over the past month.
This article was produced with the help of AI technology.
Source: Yahoo Finance
